I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| ciliated cell | 10 studies | 39% ± 18% | |
| T cell | 6 studies | 28% ± 6% | |
| B cell | 5 studies | 29% ± 8% | |
| plasmablast | 5 studies | 36% ± 21% | |
| epithelial cell | 4 studies | 26% ± 9% | |
| natural killer cell | 4 studies | 29% ± 12% | |
| CD4-positive, alpha-beta T cell | 4 studies | 40% ± 8% | |
| CD8-positive, alpha-beta T cell | 4 studies | 35% ± 8% | |
| plasma cell | 3 studies | 26% ± 8% | |
| erythroblast | 3 studies | 35% ± 16% | |
| transit amplifying cell | 3 studies | 33% ± 8% | |
| effector CD8-positive, alpha-beta T cell | 3 studies | 26% ± 7% | |
| regulatory T cell | 3 studies | 20% ± 5% |
